摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

9-[(3-bromopropyl)sulfanyl]-1,2,3,4-tetrahydroacridine | 823190-28-9

中文名称
——
中文别名
——
英文名称
9-[(3-bromopropyl)sulfanyl]-1,2,3,4-tetrahydroacridine
英文别名
9-[(3-boromopropyl)sulfanyl]-1,2,3,4-tetrahydroacridine;9-(3-Bromopropylsulfanyl)-1,2,3,4-tetrahydroacridine
9-[(3-bromopropyl)sulfanyl]-1,2,3,4-tetrahydroacridine化学式
CAS
823190-28-9
化学式
C16H18BrNS
mdl
——
分子量
336.296
InChiKey
SHYMLGMVAIYYFR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5
  • 重原子数:
    19
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.44
  • 拓扑面积:
    38.2
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    9-[(3-bromopropyl)sulfanyl]-1,2,3,4-tetrahydroacridine三乙胺N,N-二异丙基乙胺三氟乙酸 作用下, 以 二氯甲烷乙腈 为溶剂, 反应 25.0h, 生成 N-methyl-N'-(1,2,3,4-tetrahydro-acridin-9-yl)-N-[3-(1,2,3,4-tetrahydro-acridin-9-ylsulfanyl)-propyl]-propane-1,3-diamine
    参考文献:
    名称:
    Development of Molecular Probes for the Identification of Extra Interaction Sites in the Mid-Gorge and Peripheral Sites of Butyrylcholinesterase (BuChE). Rational Design of Novel, Selective, and Highly Potent BuChE Inhibitors
    摘要:
    Tacrine heterobivalent ligands were designed as novel and reversible inhibitors of cholinesterases. On the basis of the investigation of the active site gorge topology of butyrylcholinesterase (BuChE) and acetylcholinesterase (AChE) and by using flexible docking procedures, molecular modeling studies formulated the hypothesis of extra interaction sites in the active gorge of hBuChE, namely, a mid-gorge interaction site and a peripheral interaction site. The design strategy led to novel BuChE inhibitors, balancing potency and selectivity. Among the compounds identified, the heterobivalent ligand 4m, containing an amide nitrogen and a sulfur atom at the 8-membered tether level, is one of the most potent and selective BuChE inhibitors described to date. The novel inhibitors, bearing postulated key features, validated the hypothesis of the presence of extra interaction sites within the hBuChE active site gorge.
    DOI:
    10.1021/jm049510k
  • 作为产物:
    描述:
    1,3-二溴丙烷9-Thio-1,2,3,4-tetrahydroacridanone氢氧化钾 作用下, 以 乙腈 为溶剂, 反应 12.0h, 以74%的产率得到9-[(3-bromopropyl)sulfanyl]-1,2,3,4-tetrahydroacridine
    参考文献:
    名称:
    Development of Molecular Probes for the Identification of Extra Interaction Sites in the Mid-Gorge and Peripheral Sites of Butyrylcholinesterase (BuChE). Rational Design of Novel, Selective, and Highly Potent BuChE Inhibitors
    摘要:
    Tacrine heterobivalent ligands were designed as novel and reversible inhibitors of cholinesterases. On the basis of the investigation of the active site gorge topology of butyrylcholinesterase (BuChE) and acetylcholinesterase (AChE) and by using flexible docking procedures, molecular modeling studies formulated the hypothesis of extra interaction sites in the active gorge of hBuChE, namely, a mid-gorge interaction site and a peripheral interaction site. The design strategy led to novel BuChE inhibitors, balancing potency and selectivity. Among the compounds identified, the heterobivalent ligand 4m, containing an amide nitrogen and a sulfur atom at the 8-membered tether level, is one of the most potent and selective BuChE inhibitors described to date. The novel inhibitors, bearing postulated key features, validated the hypothesis of the presence of extra interaction sites within the hBuChE active site gorge.
    DOI:
    10.1021/jm049510k
点击查看最新优质反应信息

文献信息

  • Exploiting Protein Fluctuations at the Active-Site Gorge of Human Cholinesterases: Further Optimization of the Design Strategy to Develop Extremely Potent Inhibitors
    作者:Stefania Butini、Giuseppe Campiani、Marianna Borriello、Sandra Gemma、Alessandro Panico、Marco Persico、Bruno Catalanotti、Sindu Ros、Margherita Brindisi、Marianna Agnusdei、Isabella Fiorini、Vito Nacci、Ettore Novellino、Tatyana Belinskaya、Ashima Saxena、Caterina Fattorusso
    DOI:10.1021/jm701253t
    日期:2008.6.1
    network among the key substructures. This drew the optimization of our design strategy to discover potent and reversible inhibitors of human acetylcholinesterase and butyrylcholinesterase (hAChE and hBuChE) that selectively interact with specific protein substructures. Accordingly, two tricyclic moieties differently spaced by functionalized linkers were investigated as molecular yardsticks to probe the
    蛋白质构象波动对于生物学功能至关重要,尽管蛋白质运动与功能之间的关系尚待充分研究。通过对胆碱酯酶(ChEs)的全面生物信息学分析,我们确定了引起蛋白质波动和功能的特定热点,以及在关键子结构之间调节合作网络的活性位点残基。这吸引了我们设计策略的优化,以发现有效和可逆的人类乙酰胆碱酯酶和丁酰胆碱酯酶抑制剂(hAChE和hBuChE),这些抑制剂可选择性地与特定蛋白质亚结构相互作用。因此,研究了两个功能不同的连接基间隔不同的三环部分作为分子尺度,以探讨与hChE峡谷中特定热点的最佳相互作用。确定了许多SAR趋势,发现多位点抑制剂3a和3d是迄今为止已知的最有效的hBuChE和hAChE抑制剂。
  • Development of Molecular Probes for the Identification of Extra Interaction Sites in the Mid-Gorge and Peripheral Sites of Butyrylcholinesterase (BuChE). Rational Design of Novel, Selective, and Highly Potent BuChE Inhibitors
    作者:Giuseppe Campiani、Caterina Fattorusso、Stefania Butini、Alessandra Gaeta、Marianna Agnusdei、Sandra Gemma、Marco Persico、Bruno Catalanotti、Luisa Savini、Vito Nacci、Ettore Novellino、Harold W. Holloway、Nigel H. Greig、Tatyana Belinskaya、James M. Fedorko、Ashima Saxena
    DOI:10.1021/jm049510k
    日期:2005.3.1
    Tacrine heterobivalent ligands were designed as novel and reversible inhibitors of cholinesterases. On the basis of the investigation of the active site gorge topology of butyrylcholinesterase (BuChE) and acetylcholinesterase (AChE) and by using flexible docking procedures, molecular modeling studies formulated the hypothesis of extra interaction sites in the active gorge of hBuChE, namely, a mid-gorge interaction site and a peripheral interaction site. The design strategy led to novel BuChE inhibitors, balancing potency and selectivity. Among the compounds identified, the heterobivalent ligand 4m, containing an amide nitrogen and a sulfur atom at the 8-membered tether level, is one of the most potent and selective BuChE inhibitors described to date. The novel inhibitors, bearing postulated key features, validated the hypothesis of the presence of extra interaction sites within the hBuChE active site gorge.
查看更多